These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Use of bromocriptine to prevent puerperal lactation during neuroleptic treatment of chronic schizophrenia. Wolf R Pharmacopsychiatry; 1992 Sep; 25(5):240-2. PubMed ID: 1357683 [TBL] [Abstract][Full Text] [Related]
49. Lack of action of prolactin suppression on the regulation of the human menstrual cycle. del Pozo E; Goldstein M; Friesen H; Brun del Re R; Eppenberger U Am J Obstet Gynecol; 1975 Dec; 123(7):719-23. PubMed ID: 1239194 [TBL] [Abstract][Full Text] [Related]
50. Suppression of puerperal lactation using jasmine flowers (Jasminum sambac). Shrivastav P; George K; Balasubramaniam N; Jasper MP; Thomas M; Kanagasabhapathy AS Aust N Z J Obstet Gynaecol; 1988 Feb; 28(1):68-71. PubMed ID: 3214386 [TBL] [Abstract][Full Text] [Related]
51. A therapeutic role of prolactin supplementation in ovarian stimulation for in vitro fertilization: the bromocriptine-rebound method. Jinno M; Katsumata Y; Hoshiai T; Nakamura Y; Matsumoto K; Yoshimura Y J Clin Endocrinol Metab; 1997 Nov; 82(11):3603-11. PubMed ID: 9360514 [TBL] [Abstract][Full Text] [Related]
52. Prevention and suppression of post-partum lactation with 2-bromo-alpha-ergocryptine (CB-154). Macleod SC; Scott J; Lord L; Brodie G; Perlin I; Simpson AA Clin Endocrinol (Oxf); 1977; 6 Suppl():65S-70S. PubMed ID: 617072 [TBL] [Abstract][Full Text] [Related]
53. Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years. Haase R; Jaspers C; Schulte HM; Lancranja I; Pfingsten H; Orri-Fend M; Reinwein D; Benker G Clin Endocrinol (Oxf); 1993 Feb; 38(2):165-76. PubMed ID: 8435897 [TBL] [Abstract][Full Text] [Related]
55. Effects of prolactin and bromocriptine on the luteal phase in infertile women. Fredricsson B; Carlström K; Björk G; Messinis I Eur J Obstet Gynecol Reprod Biol; 1981 Apr; 11(5):319-33. PubMed ID: 6785120 [TBL] [Abstract][Full Text] [Related]
56. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea. Dickey RP; Stone SC Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580 [TBL] [Abstract][Full Text] [Related]
57. Effects of lactation and season on plasma prolactin concentrations and response to bromocriptine during lactation in the Bennett's wallaby (Macropus rufogriseus rufogriseus). Curlewis JD; White AS; Loudon AS; McNeilly AS J Endocrinol; 1986 Jul; 110(1):59-66. PubMed ID: 3755462 [TBL] [Abstract][Full Text] [Related]
58. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea. Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934 [TBL] [Abstract][Full Text] [Related]
59. The effect of chlorotrianisene as postpartum lactation suppression on blood coagulation factors. Niebyl JR; Bell WR; Schaaf ME; Blake DA; Dubin NH; King TM Am J Obstet Gynecol; 1979 Jul; 134(5):518-22. PubMed ID: 453287 [TBL] [Abstract][Full Text] [Related]
60. The importance of prolactin for lactation in the ewe. Hooley RD; Campbell JJ; Findlay JK J Endocrinol; 1978 Dec; 79(3):301-10. PubMed ID: 744926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]